A Controlled Trial Comparing Continued Zidovudine with Didanosine in Human Immunodeficiency Virus Infection
Data up to Jan 2025
Total Citations Per Year
Abstract
References (34)
The Statistical Analysis of Failure Time Data.
1981 • 10,224 citations
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
1977 • 8,468 citations
Nonparametric Estimation from Incomplete Observations
1958 • 7,673 citations
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
1987 • 3,000 citations
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
1985 • 1,830 citations
HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
1989 • 1,574 citations
The AIDS Dementia Complex
1988 • 1,387 citations
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
1990 • 1,288 citations
Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
1989 • 1,199 citations
Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDS
1984 • 1,163 citations
The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
1987 • 1,134 citations
Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.
1986 • 1,032 citations
Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infection
1991 • 755 citations
The Safety and Efficacy of Zidovudine (AZT) in the Treatment of Subjects with Mildly Symptomatic Human Immunodeficiency Virus Type 1 (HIV) Infection
1990 • 598 citations
In Vivo Activity Against HIV and Favorable Toxicity Profile of 2′,3′-Dideoxyinosine
1989 • 426 citations
2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related Complex
1990 • 391 citations
Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related Dideoxynucleosides
1989 • 356 citations
A Randomized Controlled Trial of a Reduced Daily Dose of Zidovudine in Patients with the Acquired Immunodeficiency Syndrome
1990 • 330 citations
A Controlled Trial of Early versus Late Treatment with Zidovudine in Symptomatic Human Immunodeficiency Virus Infection
1992 • 328 citations
Once-Daily Administration of 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related Complex
1990 • 253 citations
Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complex
1990 • 217 citations
The Effects on Survival of Early Treatment of Human Immunodeficiency Virus Infection
1992 • 213 citations
Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus.
1990 • 204 citations
Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro.
1987 • 201 citations
Combining Dependent Tests with Incomplete Repeated Measurements
1985 • 190 citations
Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy
1989 • 181 citations
Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy
1990 • 180 citations
Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS
1991 • 153 citations
Initial studies on the cellular pharmacology of 2′,3′-dideoxyinosine, an inhibitor of HIV infectivity
1987 • 142 citations
Inhibition of immune functions by antiviral drugs.
1991 • 137 citations
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group
1989 • 110 citations
Decreased In Vitro Susceptibility to Zidovudine of HIV Isolates Obtained from Patients with AIDS
1990 • 100 citations
Susceptibility to nucleoside analogues of zidovudine-resistant isolates of human immunodeficiency virus
1990 • 52 citations
Adjusting for early treatment termination in comparative clinical trials
1990 • 46 citations
Cited By (0)
No citing papers found in database